Early phase evaluation of COVID-19 therapeutics
University of Liverpool, Liverpool, UK
Saye Khoo, MD, PhD, is Professor in the Department of Pharmacology at the University of Liverpool, and Honorary Consultant Physician in Infectious Diseases at the Royal Liverpool University Hospital. His research focuses on infection pharmacology, including optimising dosing for special populations and drug-drug interactions in the treatment and prevention of HIV and TB.
He leads the international DolPHIN consortium studying safe and effective use of anti-retrovirals in pregnancy, and provides clinical leadership for Liverpool Drug Interactions programme (www.druginteractions.org). He is also Chief Investigator for the AGILE Phase I/II platform for SARS CoV2 therapies (www.agiletrial.net).